A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer's Disease.
- Published in:
- CNS Drugs, 2024, v. 38, n. 7, p. 493, doi. 10.1007/s40263-024-01097-w
- By:
- Publication type:
- Article
Works matching IS 11727047 AND DT 2024 AND VI 38 AND IP 7
Results: 6
1
2
Targeting Biometals in Alzheimer's Disease with Metal Chelating Agents Including Coumarin Derivatives.
- Published in:
- CNS Drugs, 2024, v. 38, n. 7, p. 507, doi. 10.1007/s40263-024-01093-0
- By:
- Publication type:
- Article
3
Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics.
- Published in:
- CNS Drugs, 2024, v. 38, n. 7, p. 571, doi. 10.1007/s40263-024-01092-1
- By:
- Publication type:
- Article
4
Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy.
- Published in:
- CNS Drugs, 2024, v. 38, n. 7, p. 533, doi. 10.1007/s40263-024-01091-2
- By:
- Publication type:
- Article
5
Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia.
- Published in:
- CNS Drugs, 2024, v. 38, n. 7, p. 559, doi. 10.1007/s40263-024-01089-w
- By:
- Publication type:
- Article
6
Observation on the Analgesic Effect of Different Doses of a Combination of Esketamine and Dexmedetomidine Administered for Percutaneous Endoscopic Transforaminal Discectomy: A Randomized, Double-Blind Controlled Trial.
- Published in:
- CNS Drugs, 2024, v. 38, n. 7, p. 547, doi. 10.1007/s40263-024-01083-2
- By:
- Publication type:
- Article